LDS/Medical Tests/Kallmann Syndrome, Xp22.3 Deletion, FISH

Kallmann Syndrome, Xp22.3 Deletion, FISH

Kallmann syndrome (KS) is a congenital form of hypogonadotropic hypogonadism caused by disrupted migration of gonadotropin-releasing hormone (GnRH) and olfactory neurons during embryogenesis. One key genetic etiology is the deletion of the ANOS1 gene (formerly KAL1) located on Xp22.3 chromosomal region. ANOS1 encodes anosmin-1, an extracellular matrix protein critical for the development of olfactory axons and GnRH-secreting neurons. Complete deletions of Xp22.3 may encompass additional loci, potentially contributing to broader phenotypic manifestations.

The condition is more prevalent in males (approx. 1 in 30,000) due to X-linked inheritance, with females (approx. 1 in 120,000) typically presenting with milder phenotypes or being asymptomatic carriers. Key clinical features include delayed or absent puberty, anosmia or hyposmia, cryptorchidism, micropenis, and infertility. In females, features may include primary amenorrhea and absent secondary sexual characteristics. Additional phenotypes such as cleft palate, bimanual synkinesis, hearing loss, and skeletal anomalies may also occur, especially with contiguous gene deletions.

  • Diagnosis of Kallmann syndrome in patients presenting with anosmia and delayed puberty
  • Neonatal screening in cases with genital anomalies
  • Differential diagnosis of Kallmann syndrome from other forms of hypogonadotropic hypogonadism

The presence of locus p22.3 on chromosome X indicates normal genome and rules out Xp22.3 deletion as a cause of hypogonadism.

Absence of Xp22.3 locus (ANOS1) indicates deletion; supports diagnosis of X-linked Kallmann syndrome

Negative (No deletion of Xp22.3)

Fluorescent In-Situ Hybridization (FISH), a targeted cytogenetic technique that detects chromosomal deletions or rearrangements at Xp22.3, Comparative genomic hybridization.

Whole blood, heparinized vial (green-top).

Stability

  • Ambient: 24 hrs.
  • Refrigerated: 3-5 days
  • Frozen: unacceptable
Hormonal profile (TSH, free T4, FSH, LH, prolactin, testosterone, estradiol, progesterone) to assess pituitary and gonadal axis functionality.
3-5 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login